Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

AbbVie (NYSE:ABBV) has been actively advancing its oncology portfolio with recent presentations at the AACR Annual Meeting, ...

The European Commission (EC) has granted marketing authorization to Rinvoq (upadacitinib; 15mg, once daily), from US pharma ...

AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Highlights,Market sentiment surrounding AbbVie (NYSE:ABBV) has shifted following rating changes and price objective ...

AbbVie is scheduled to report first-quarter earnings on April 25. Healthcare & Pharmaceuticalscategory US aims to uncover autism cause by September after eluding scientists for decades 7:24 PM UTC ...

The global US Autoinjectors Market is projected to expand to a value of US$1.45 billion in 2030 from US$0.65 billion in 2024, ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 ...